Date	Period	Revenue/Estimate	Earnings Call
Jul 31, 2024	2025/Q1	28.419B / --	--
Feb 6, 2024	2024/Q3	32.330B / --	--
Aug 2, 2023	2024/Q1	27.854B / --	--
Feb 6, 2023	2023/Q3	31.614B / --	--
Aug 2, 2022	2023/Q1	24.619B / --	--

DatePeriodRevenue/EstimateEarnings Call

Jul 31, 20242025/Q128.419B / ----

Feb 6, 20242024/Q332.330B / ----

Aug 2, 20232024/Q127.854B / ----

Feb 6, 20232023/Q331.614B / ----

Aug 2, 20222023/Q124.619B / ----

Unlock Free Earnings Estimates

Open Account

Kyorin Pharmaceutical Earnings Reports

Kyorin Pharmaceutical: Confirmation letter

Nov 13, 2024 01:27 ET

Kyorin Pharmaceutical: Interim Report - 67th term (2024/04/01 - 2025/03/31)

Nov 13, 2024 01:24 ET

Kyorin Pharmaceutical: Notice regarding differences between consolidated earnings forecasts and actual results for the second quarter (interim period) of the fiscal year ending March 31, 2025

Nov 7, 2024 01:30 ET

Kyorin Pharmaceutical: Supplementary financial information for the 2nd quarter (interim period) of the fiscal year ending March 31, 2025

Nov 7, 2024 01:30 ET

Symbol Price % Chg